3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Cancer Pain: new trials by email Literature Review of Cancer Pain trials Research Report on Cancer Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients Fentanyl Buccal Tablet (FBT) - Cancer Pain, Breakthrough Pain | Phase 4 | Terminated | Cephalon | 330 | 2009-01-01 | 2012-10-01 |
| Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain fentanyl - Pain | Phase 4 | Terminated | Janssen Cilag S.A.S. | 34 | 2003-06-01 | 2011-05-17 |
| A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) MK0966; rofecoxib / Duration of Treatment: 24 weeks, Comparator: placebo / Duration of Treatment: 24 weeks - Adenomatous Polyposis Coli | Phase 4 | Terminated | Merck Sharp & Dohme LLC | 62 | 2002-08-06 | 2019-09-20 |
Adenomatous Polyposis Coli (1) · Agnosia (1) · Breakthrough Pain (1) · Osteoarthritis (1) · Pain (1)
Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Pain (2) · Adenoma (1) · Adenomatous Polyps (1) · Arthritis (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genetic Diseases, Inborn (1)
Fentanyl (2) · Duration of Therapy (1) · rofecoxib (1)
Cephalon (1) · Janssen Cilag S.A.S. (1) · Merck Sharp & Dohme LLC (1)
France (1) · Germany (1) · Ireland (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1)
2008 (1)